Acetylsalicylic Acid Is Associated With a Lower Prevalence of Ascending Aortic Aneurysm and a Decreased Aortic Expression of Cyclooxygenase 2
Background Acetylsalicylic acid (ASA) therapy has been associated with a reduced prevalence and growth rate of abdominal as well as intracranial aneurysms, but the relationship between ASA and ascending aortic aneurysm formation remains largely unknown. The aim of the present study was to investigat...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-05-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.121.024346 |
| _version_ | 1811267033327730688 |
|---|---|
| author | Carl Granath David Freiholtz Fredrik Bredin Christian Olsson Anders Franco‐Cereceda Hanna M. Björck |
| author_facet | Carl Granath David Freiholtz Fredrik Bredin Christian Olsson Anders Franco‐Cereceda Hanna M. Björck |
| author_sort | Carl Granath |
| collection | DOAJ |
| description | Background Acetylsalicylic acid (ASA) therapy has been associated with a reduced prevalence and growth rate of abdominal as well as intracranial aneurysms, but the relationship between ASA and ascending aortic aneurysm formation remains largely unknown. The aim of the present study was to investigate whether ASA therapy is associated with a lower prevalence of ascending aortic aneurysm in a surgical cohort. Methods and Results One thousand seven hundred patients undergoing open‐heart surgery for ascending aortic aneurysm and/or aortic valve disease were studied in this retrospective cross‐sectional study. Aortic dilatation was defined as an aortic root or ascending aortic diameter ≥45 mm. Medications were self‐reported by the patients in a systematic questionnaire. Cyclooxygenase gene expression was measured in the intima‐media portion of the ascending aorta (n=117). In a multivariable analysis, ASA was associated with a reduced prevalence of ascending aortic aneurysm (relative risk, 0.68 [95% CI, 0.48–0.95], P=0.026) in patients with tricuspid aortic valves, but not in patients with bicuspid aortic valves (relative risk, 0.93 [95% CI, 0.64–1.34], P=0.687). Intima‐media cyclooxygenase expression was positively correlated with ascending aortic dimensions (P<0.001 for cyclooxygenase‐1 and P=0.05 for cyclooxygenase‐2). In dilated, but not nondilated tricuspid aortic valve aortic specimens, ASA was associated with significantly lower cyclooxygenase‐2 levels (P=0.034). Conclusions Our findings are consistent with the hypothesis that ASA treatment may attenuate ascending aortic aneurysmal growth, possibly via cyclooxygenase‐2 inhibition in the ascending aortic wall and subsequent anti‐inflammatory actions. |
| first_indexed | 2024-04-12T20:54:05Z |
| format | Article |
| id | doaj.art-e1b645db17564eff9e79b4d66e841326 |
| institution | Directory Open Access Journal |
| issn | 2047-9980 |
| language | English |
| last_indexed | 2024-04-12T20:54:05Z |
| publishDate | 2022-05-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| spelling | doaj.art-e1b645db17564eff9e79b4d66e8413262022-12-22T03:17:02ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802022-05-0111910.1161/JAHA.121.024346Acetylsalicylic Acid Is Associated With a Lower Prevalence of Ascending Aortic Aneurysm and a Decreased Aortic Expression of Cyclooxygenase 2Carl Granath0David Freiholtz1Fredrik Bredin2Christian Olsson3Anders Franco‐Cereceda4Hanna M. Björck5Section of Cardiothoracic Surgery Department of Molecular Medicine and Surgery Karolinska Institutet Stockholm SwedenSection of Cardiothoracic Surgery Department of Molecular Medicine and Surgery Karolinska Institutet Stockholm SwedenSection of Cardiothoracic Surgery Department of Molecular Medicine and Surgery Karolinska Institutet Stockholm SwedenSection of Cardiothoracic Surgery Department of Molecular Medicine and Surgery Karolinska Institutet Stockholm SwedenSection of Cardiothoracic Surgery Department of Molecular Medicine and Surgery Karolinska Institutet Stockholm SwedenCardiovascular Medicine Unit Center for Molecular Medicine Department of Medicine Karolinska Institutet, StockholmKarolinska University Hospital Solna SwedenBackground Acetylsalicylic acid (ASA) therapy has been associated with a reduced prevalence and growth rate of abdominal as well as intracranial aneurysms, but the relationship between ASA and ascending aortic aneurysm formation remains largely unknown. The aim of the present study was to investigate whether ASA therapy is associated with a lower prevalence of ascending aortic aneurysm in a surgical cohort. Methods and Results One thousand seven hundred patients undergoing open‐heart surgery for ascending aortic aneurysm and/or aortic valve disease were studied in this retrospective cross‐sectional study. Aortic dilatation was defined as an aortic root or ascending aortic diameter ≥45 mm. Medications were self‐reported by the patients in a systematic questionnaire. Cyclooxygenase gene expression was measured in the intima‐media portion of the ascending aorta (n=117). In a multivariable analysis, ASA was associated with a reduced prevalence of ascending aortic aneurysm (relative risk, 0.68 [95% CI, 0.48–0.95], P=0.026) in patients with tricuspid aortic valves, but not in patients with bicuspid aortic valves (relative risk, 0.93 [95% CI, 0.64–1.34], P=0.687). Intima‐media cyclooxygenase expression was positively correlated with ascending aortic dimensions (P<0.001 for cyclooxygenase‐1 and P=0.05 for cyclooxygenase‐2). In dilated, but not nondilated tricuspid aortic valve aortic specimens, ASA was associated with significantly lower cyclooxygenase‐2 levels (P=0.034). Conclusions Our findings are consistent with the hypothesis that ASA treatment may attenuate ascending aortic aneurysmal growth, possibly via cyclooxygenase‐2 inhibition in the ascending aortic wall and subsequent anti‐inflammatory actions.https://www.ahajournals.org/doi/10.1161/JAHA.121.024346ascending aortic aneurysmaspirinCOX‐2 |
| spellingShingle | Carl Granath David Freiholtz Fredrik Bredin Christian Olsson Anders Franco‐Cereceda Hanna M. Björck Acetylsalicylic Acid Is Associated With a Lower Prevalence of Ascending Aortic Aneurysm and a Decreased Aortic Expression of Cyclooxygenase 2 Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease ascending aortic aneurysm aspirin COX‐2 |
| title | Acetylsalicylic Acid Is Associated With a Lower Prevalence of Ascending Aortic Aneurysm and a Decreased Aortic Expression of Cyclooxygenase 2 |
| title_full | Acetylsalicylic Acid Is Associated With a Lower Prevalence of Ascending Aortic Aneurysm and a Decreased Aortic Expression of Cyclooxygenase 2 |
| title_fullStr | Acetylsalicylic Acid Is Associated With a Lower Prevalence of Ascending Aortic Aneurysm and a Decreased Aortic Expression of Cyclooxygenase 2 |
| title_full_unstemmed | Acetylsalicylic Acid Is Associated With a Lower Prevalence of Ascending Aortic Aneurysm and a Decreased Aortic Expression of Cyclooxygenase 2 |
| title_short | Acetylsalicylic Acid Is Associated With a Lower Prevalence of Ascending Aortic Aneurysm and a Decreased Aortic Expression of Cyclooxygenase 2 |
| title_sort | acetylsalicylic acid is associated with a lower prevalence of ascending aortic aneurysm and a decreased aortic expression of cyclooxygenase 2 |
| topic | ascending aortic aneurysm aspirin COX‐2 |
| url | https://www.ahajournals.org/doi/10.1161/JAHA.121.024346 |
| work_keys_str_mv | AT carlgranath acetylsalicylicacidisassociatedwithalowerprevalenceofascendingaorticaneurysmandadecreasedaorticexpressionofcyclooxygenase2 AT davidfreiholtz acetylsalicylicacidisassociatedwithalowerprevalenceofascendingaorticaneurysmandadecreasedaorticexpressionofcyclooxygenase2 AT fredrikbredin acetylsalicylicacidisassociatedwithalowerprevalenceofascendingaorticaneurysmandadecreasedaorticexpressionofcyclooxygenase2 AT christianolsson acetylsalicylicacidisassociatedwithalowerprevalenceofascendingaorticaneurysmandadecreasedaorticexpressionofcyclooxygenase2 AT andersfrancocereceda acetylsalicylicacidisassociatedwithalowerprevalenceofascendingaorticaneurysmandadecreasedaorticexpressionofcyclooxygenase2 AT hannambjorck acetylsalicylicacidisassociatedwithalowerprevalenceofascendingaorticaneurysmandadecreasedaorticexpressionofcyclooxygenase2 |